Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta-endorphin in the human gallbladder.

I Shimizu, M Matsumura, M Hirota

    Regulatory Peptides
    |December 30, 1986
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    A new Kumazawa-type rock deformation apparatus for improved stress measurements at confining pressures up to 2 GPa.

    The Review of scientific instruments·2026
    Same author

    Search for Majorana Neutrinos with the Complete KamLAND-Zen Dataset.

    Physical review letters·2026
    Same author

    Search for the Majorana Nature of Neutrinos in the Inverted Mass Ordering Region with KamLAND-Zen.

    Physical review letters·2023
    Same author

    Peripherally inserted central catheter line-related deep venous thrombosis.

    Anaesthesia reports·2022
    Same author

    Relation of Poor Nutritional Status to Mild Cognitive Impairment in Patients with Coronary Artery Disease.

    The journal of nutrition, health & aging·2020
    Same author

    Precision Analysis of the ^{136}Xe Two-Neutrino ββ Spectrum in KamLAND-Zen and Its Impact on the Quenching of Nuclear Matrix Elements.

    Physical review letters·2019

    Human gallbladder contains beta-endorphin-like immunoreactivity (beta-END-LI) which is released by cholecystokinin octapeptide (CCK-8). This suggests a potential role for beta-END-LI in gallbladder function or disease.

    Area of Science:

    • Gastroenterology
    • Endocrinology
    • Neuroscience

    Background:

    • Beta-endorphin-like immunoreactivity (beta-END-LI) has been identified in various tissues.
    • The presence and function of beta-END-LI in the human gallbladder remain largely unexplored.

    Purpose of the Study:

    • To investigate the presence and characteristics of beta-END-LI in the human gallbladder.
    • To examine the release of beta-END-LI from the gallbladder in response to cholecystokinin octapeptide (CCK-8).

    Main Methods:

    • Radioimmunochemical measurements and immunohistochemical stainings were employed.
    • Gel-filtration chromatography was used to analyze beta-END-LI components.
    • Human gallbladder mucosa was perfused with CCK-8 to assess beta-END-LI release.

    Related Experiment Videos

    Main Results:

    • Beta-END-LI was detected in the human gallbladder at significant levels.
    • Immunoreactivity analysis confirmed the similarity of gallbladder beta-END-LI to synthetic beta-endorphin.
    • Two components of beta-END-LI were identified, corresponding to beta-lipotropin (beta-LPH) and beta-endorphin.
    • CCK-8 perfusion significantly increased the release of beta-END-LI from gallbladder mucosa.

    Conclusions:

    • The human gallbladder contains beta-END-LI, with components resembling beta-LPH and beta-endorphin.
    • Cholecystokinin octapeptide (CCK-8) directly stimulates the release of beta-END-LI from gallbladder mucosa.
    • These findings suggest a potential physiological or pathophysiological role for beta-END-LI in the human gallbladder.